Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 28

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

437

HTML

4873

Figures (1-3)

317

Tables (1-4)

245

Sum=5872

Jul 28, 2010 (publication date) through Feb 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 28, 2010; 16(28): 3584-3591
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3584

Table 2 Tumor volume of the vaccinated and high-intensity focused ultrasound-treated mice after a subsequent H22 tumor challenge (mean ± SD)

	Average tumor volume (mm³) after H22 tumor challenge
	2 wk	3 wk	4 wk
Control group	343.3 ± 129.5	829.3 ± 316.4	1953.0 ± 848.2
Tumor vaccine group	504.1 ± 173.7	733.4 ± 301.3	1760.2 ± 1075.1
HIFU vaccine group	279.7 ± 117.2	382.8 ± 170.6^a^d	914.3 ± 474.2^a^d
HIFU therapy group	0	0	0

^aP < 0.05 vs the tumor vaccine group;

^dP < 0.01 vs the control group. HIFU: High-intensity focused ultrasound.

Citation: Zhang Y, Deng J, Feng J, Wu F. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. World J Gastroenterol 2010; 16(28): 3584-3591
URL: https://www.wjgnet.com/1007-9327/full/v16/i28/3584.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i28.3584